Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil and C2 domain-containing protein 1A (CC2D1A) is a highly conserved protein encoded by the CC2D1A gene. It functions as a transcriptional repressor, originally identified for repressing the serotonin receptor 1A gene in neurons. CC2D1A also acts as a scaffold protein, anchoring components of the PI3K/Akt pathway and influencing signal transduction and cell survival pathways. In cancer biology, elevated CC2D1A expression correlates with poor prognosis and resistance to chemotherapy in ovarian cancer, mechanistically contributing to survival signaling and reduced apoptosis. Additionally, inherited mutations in CC2D1A cause autosomal recessive intellectual disability, consistent with its neuronal roles[1][2][3].
Chemoresistance promotion through modulation of apoptosis and survival pathways, potentially via NFκB and Akt pathway scaffolding[1][2] Transcriptional repression of the serotonin receptor 1A gene in neuronal cells[3]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil and C2 domain-containing protein 1A (CC2D1A).